Non-bank mortgage lender MA Money has followed up its highly successful Prime Time pricing campaign with further interest rate reductions across its prime product suite, while also scrapping the large loan loading.
MA Money national sales manager Tim Lemon (pictured) said the updated pricing, effective from Sept. 8, was driven by strong broker response to the earlier promotion.
The reduced rates now start from:
5.84% p.a. for Full Doc loans (comparison rate 5.88% p.a.*)
6.04% p.a. for Alt Doc loans (comparison rate 6.10% p.a.*)
Full Doc loans suit borrowers with easily verifiable income, while Alt Doc products cater to self-employed or non-traditional earners. Lemon said the campaign was designed around flexibility, service, and quick turnarounds to help brokers win more deals in a competitive market.
Lemon said brokers had given strong feedback on the Prime Time campaign, praising both the competitive rates and the speed and support provided.
“Brokers are consistently telling us how fast we’re moving,” he said. “We’ve had deals conditionally approved within 48 hours, and in some cases formal approval has landed within the same day. It shows how well our credit team and business development managers (BDMs) work in partnership with brokers to get deals over the line.”
Lemon confirmed the changes apply to loans up to $2.5 million at 65% LVR and form part of a broader rate review covering vacant land, expat, non-resident, and SMSF loans.
“MA Money has also removed the large loan loading on loans between $1.75 million and $2.5 million, giving brokers greater flexibility for higher-value scenarios,” he said.
He added that MA Money continues to apply a “common-sense credit approach,” avoiding credit scoring, CCR, and DTI restrictions, while relying on BDM support and scenario specialists to deliver certainty.
Brokers can access the updated rates via MA Money’s Broker Resources page and are encouraged to contact their dedicated BDM for support or scenario discussions.
Get the hottest and freshest mortgage news delivered right into your inbox. Subscribe now to our FREE daily newsletter.
